Recent research reveals that blocking an inflammation-promoting protein, IL-11, can significantly extend the lifespan and improve the health of laboratory …
Artiva Biotherapeutics, a clinical-stage biotechnology company, has raised $167 million through its initial public offering (IPO). The company offered 13.9 …
Technology-driven biotech startup CytoReason, a developer of computational disease models, has raised $80 million from a consortium of investors, including …
Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has presented significant advancements in its AI-Immunology™ platform, specifically focusing on …
US-based brain-computer interface (BCI) company Synchron has integrated generative AI into its brain implant interface system, enhancing the ability of …
French startup Bioptimus has released H-optimus-0, the largest open-source AI foundation model for pathology. With 1.1 billion parameters, this model …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
